Trade

with

SurModics Inc
(NASDAQ: SRDX)
AdChoices
20.75
+0.06
+0.29%
After Hours :
20.75
0.00
0.00%

Open

20.78

Previous Close

20.69

Volume (Avg)

44.28k (44.02k)

Day's Range

20.52-21.01

52Wk Range

18.00-25.99

Market Cap.

281.32M

Dividend Rate ( Yield )

-

Beta

1.21

Shares Outstanding

13.60M

P/E Ratio (EPS)

21.51 (0.95)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Diagnostics & Research
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 56.13M

    • Net Income

    • 15.17M

    • Market Cap.

    • 281.32M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 23.71

    • PEG (Price/Earnings Growth) Ratio

    • 1.39

    • Beta

    • 1.21

    • Forward P/E

    • 20.96

    • Price/Sales

    • 5.16

    • Price/Book Value

    • 2.98

    • Price/Cash flow

    • 15.80

      • EBITDA

      • 21.71M

      • Return on Capital %

      • 13.07

      • Return on Equity %

      • 13.88

      • Return on Assets %

      • 13.07

      • Book Value/Share

      • 6.96

      • Shares Outstanding

      • 13.60M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Buy
        • 1 Year Price Target

        • 29.00

        • Credit Rating

        • -

        • Analysts

        • 2

        • EPS Estimate

        • 0.96

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 2.30

          • 21.91

          • Net Income

            YTD/YTD (last year)

          • 43.90

          • -5.55

          • Net Income

            Q/Q (last year)

          • 15.60

          • 0.44

          • Sales (Revenue)

            5-Year Annual Average

          • -10.37

          • 47.82

          • Net Income

            5-Year Annual Average

          • -0.20

          • 4.98

          • Dividends

            5-Year Annual Average

          • -

          • 5.31

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 86.27

            • 42.70

            • Pre-Tax Margin

            • 35.05

            • 11.63

            • Net Profit Margin

            • 23.71

            • 9.55

            • Average Gross Margin

              5-Year Annual Average

            • 80.60

            • 43.76

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 12.60

            • 11.34

            • Average Net Profit Margin

              5-Year Annual Average

            • 5.70

            • 52.13B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.62

              • Current Ratio

              • 12.34

              • 1.23

              • Quick Ratio

              • 11.12

              • 0.76

              • Interest Coverage

              • -

              • 5.98

              • Leverage Ratio

              • 1.06

              • 2.16

              • Book Value/Share

              • 6.96

              • 14.94

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 21.46

                • 33.22

                • P/E Ratio 5-Year High

                • 30.56

                • 325.07

                • P/E Ratio 5-Year Low

                • 8.61

                • 154.73

                • Price/Sales Ratio

                • 5.14

                • 2.34

                • Price/Book Value

                • 2.96

                • 3.04

                • Price/Cash Flow Ratio

                • 15.80

                • 19.08

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 13.88

                    (5.40)

                  • 9.34

                    (9.80)

                  • Return on Assets %

                    (5-Year Average)

                  • 13.07

                    (4.60)

                  • 4.63

                    (5.44)

                  • Return on Capital %

                    (5-Year Average)

                  • 13.88

                    (5.40)

                  • 5.73

                    (6.77)

                  • Income/Employee

                  • 117.31k

                  • 17.17k

                  • Inventory Turnover

                  • 2.53

                  • 5.07

                  • Asset Turnover

                  • 0.55

                  • 0.48

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  18.82M
                  Operating Margin
                  33.53
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  15.80
                  Ownership

                  Institutional Ownership

                  85.02%

                  Top 10 Institutions

                  45.59%

                  Mutual Fund Ownership

                  44.71%

                  Float

                  84.15%

                  5% / Insider Ownership

                  24.00%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Mairs & Power Growth Fund

                  •  

                    628,800

                  • 0.00

                  • 4.62

                  • Royce Pennsylvania Mutual

                  •  

                    346,900

                  • 0.00

                  • 2.55

                  • iShares Core S&P Small-Cap (AU)

                  •  

                    276,229

                  • 0.20

                  • 2.31

                  • Vanguard Total Stock Mkt Idx

                  •  

                    224,077

                  • 0.00

                  • 1.65

                  • TETON Westwood Mighty Mites Fund

                  •  

                    216,364

                  • 50.20

                  • 1.59

                  • Royce Micro Cap Series Fund

                  •  

                    215,722

                  • -6.50

                  • 1.59

                  • iShares Russell 2000 (AU)

                  •  

                    202,197

                  • -1.46

                  • 1.69

                  • Royce Capital Fund Micro-Cap Portfolio

                  •  

                    179,378

                  • 9.13

                  • 1.32

                  • JPMorgan Small Cap Value

                  •  

                    174,000

                  • 0.00

                  • 1.28

                  • DFA U.S. Micro Cap Portfolio

                  •  

                    173,655

                  • 0.00

                  • 1.28

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Wellington Management Company, LLP

                  •  

                    1,040,575

                  • +18.97%

                  • 7.65

                  • Royce & Associates, LLC

                  •  

                    744,800

                  • +1.57%

                  • 5.48

                  • Mairs & Power Inc

                  •  

                    738,470

                  • -0.14%

                  • 5.43

                  • BlackRock Fund Advisors

                  •  

                    732,720

                  • -6.47%

                  • 5.39

                  • J.P. Morgan Investment Management Inc.

                  •  

                    546,608

                  • +1.72%

                  • 4.02

                  • Vanguard Group, Inc.

                  •  

                    534,967

                  • +1.13%

                  • 3.94

                  • Segall Bryant & Hamill

                  •  

                    519,663

                  • -53.38%

                  • 3.82

                  • Renaissance Technologies Corp

                  •  

                    504,238

                  • -1.21%

                  • 3.71

                  • Dimensional Fund Advisors, Inc.

                  •  

                    487,359

                  • +2.48%

                  • 3.58

                  • State Street Corp

                  •  

                    349,471

                  • -4.30%

                  • 2.57

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Diagnostics & Research

                  Type

                  Slow Growth

                  Style

                  Small Core

                  SurModics, Inc. was organized as a Minnesota corporation in June 1979. The Company is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The Company’s core offerings include surface mo...moredification coating technologies that impart lubricity, prohealing, and biocompatibility characteristics and components for in vitro diagnostic test kits and specialized surfaces for cell culture and microarrays. It partners with many of the emerging medical device, pharmaceutical and life science companies to develop and commercialize innovative products designed to improve patient outcomes. Although its drug delivery and surface modification technologies themselves are not directly regulated by the Food and Drug Administration, the medical devices, pharmaceutical and bi...moreotechnology products incorporating its technologies are subject to FDA regulation.lessless

                  Key People

                  Mr. Gary R. Maharaj

                  CEO/Director/President

                  Scott R. Ward

                  Director/Chairman of the Board

                  Mr. Andy LaFrence

                  CFO/Vice President, Divisional

                  Mr. Joseph Stich

                  General Manager, Divisional/Vice President

                  Timothy J. Arens

                  Vice President, Divisional

                  • SurModics Inc

                  • 9924 West 74th Street

                  • Eden Prairie, MN 55344

                  • USA.Map

                  • Phone: +1 952 500-7000

                  • Fax: +1 952 500-7001

                  • surmodics.com

                  Incorporated

                  1979

                  Employees

                  114

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: